Literature DB >> 19695461

Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression.

Larisa G Tereshchenko1, Mitchell N Faddis, Barry J Fetics, Karl E Zelik, Igor R Efimov, Ronald D Berger.   

Abstract

OBJECTIVES: This study aimed to identify an early marker of functional impairment after an implantable cardioverter-defibrillator (ICD) shock as a predictor of heart failure progression.
BACKGROUND: The ICD population has substantial risk of death due to progressive pump failure.
METHODS: Near-field (NF) bipolar right ventricular (RV) electrograms (EGMs) during induced ventricular fibrillation (VF) and 10 s after rescue ICD shock were analyzed in 310 patients (mean age 59 +/- 14.5 years, 219 men [71%]) with structural heart disease, New York Heart Association functional class I to III, and implanted with a single- or dual-chamber Medtronic (Minneapolis, Minnesota) ICD for primary (245 patients, 79%) or secondary prevention of sudden cardiac arrest. A local injury current (LIC) on NF RV EGM was defined as a deviation of EGM potential > or =1 mV or > or =15% of the preceding R-wave peak-to-peak amplitude.
RESULTS: During mean follow-up of 29.3 +/- 15.0 months, the combined end point of death or hospitalization due to congestive heart failure (CHF) exacerbation was documented in 40 patients (12.9%, or 5.3% per person-year of follow-up). LIC was observed in 106 patients. In multivariate risk analysis, after adjustment for baseline prognostic factors (ejection fraction, history of atrial fibrillation, diabetes mellitus) and appropriate ICD shocks during follow-up, patients with observed LIC after induced VF rescue ICD shock at ICD implantation were more likely to die or to be hospitalized (hazard ratio: 2.69; 95% confidence interval: 1.41 to 5.14; p = 0.003).
CONCLUSIONS: Transient LIC on bipolar NF RV EGM after induced VF rescue ICD shock is associated with increased risk of CHF progression, future hospitalizations due to CHF exacerbation, and subsequent heart failure death. 2009 by the American College of Cardiology Foundation

Entities:  

Mesh:

Year:  2009        PMID: 19695461      PMCID: PMC2803080          DOI: 10.1016/j.jacc.2009.06.004

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  37 in total

1.  Current of injury predicts acute performance of catheter-delivered active fixation pacing leads.

Authors:  Damian P Redfearn; Lorne J Gula; Andrew D Krahn; Allan C Skanes; George J Klein; Raymond Yee
Journal:  Pacing Clin Electrophysiol       Date:  2007-12       Impact factor: 1.976

2.  Current of injury (COI) pattern recorded from catheter delivered active fixation pacing leads.

Authors:  Berry M van Gelder; Frank A Bracke
Journal:  Pacing Clin Electrophysiol       Date:  2008-06       Impact factor: 1.976

3.  Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead.

Authors:  Nikolaos I Nikolaou; Stavros G Spanodimos; Elias P Tsaglis; Dionysios G Antonatos; Sotiris P Patsilinakos; Georgios M Fournarakis; Dimitrios L Tsigas
Journal:  Pacing Clin Electrophysiol       Date:  2005-11       Impact factor: 1.976

Review 4.  Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.

Authors:  Charles D Swerdlow; Michael Shehata; Peng-Sheng Chen
Journal:  Pacing Clin Electrophysiol       Date:  2007-02       Impact factor: 1.976

Review 5.  Electroporation of the heart.

Authors:  Vladimir P Nikolski; Igor R Efimov
Journal:  Europace       Date:  2005-09       Impact factor: 5.214

6.  Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Authors:  John D Day; Rahul N Doshi; Peter Belott; Ulrika Birgersdotter-Green; Mahnaz Behboodikhah; Peter Ott; Kathryn A Glatter; Serge Tobias; Howard Frumin; Byron K Lee; John Merillat; Isaac Wiener; Samuel Wang; Harlan Grogin; Sung Chun; Rob Patrawalla; Brian Crandall; Jeffrey S Osborn; J Peter Weiss; Donald L Lappe; Stacey Neuman
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

7.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Authors:  James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

8.  Effect of transvenous cardiac resynchronization therapy device implantation on cardiac troponin I release.

Authors:  Timucin Altin; Omer Akyurek; Kutay Vurgun; Osman Beton; Tamer Sayin; Mustafa Kilickap; Remzi Karaoguz; Muharrem Guldal; Cetin Erol
Journal:  Pacing Clin Electrophysiol       Date:  2007-11       Impact factor: 1.976

9.  Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.

Authors:  Thomy Schefer; Thomas Wolber; Christian Binggeli; Johannes Holzmeister; Corinna Brunckhorst; Firat Duru
Journal:  Europace       Date:  2008-08-07       Impact factor: 5.214

10.  Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.

Authors:  Douglas S Lee; Jack V Tu; Peter C Austin; Paul Dorian; Raymond Yee; Alice Chong; David A Alter; Andreas Laupacis
Journal:  J Am Coll Cardiol       Date:  2007-06-11       Impact factor: 24.094

View more
  14 in total

Review 1.  Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.

Authors:  Jacinthe Boulet; Emmanuelle Massie; Blandine Mondésert; Yoan Lamarche; Michel Carrier; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2019-12

2.  A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.

Authors:  Ajit H Janardhan; Wenwen Li; Vadim V Fedorov; Michael Yeung; Michael J Wallendorf; Richard B Schuessler; Igor R Efimov
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

3.  Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram.

Authors:  Peter Stempniewicz; Alan Cheng; Allison Connolly; Xin Yuan Wang; Hugh Calkins; Gordon F Tomaselli; Ronald D Berger; Larisa G Tereshchenko
Journal:  J Cardiovasc Electrophysiol       Date:  2010-11-18

4.  Construction of intracardiac vectorcardiogram from implantable cardioverter-defibrillator intracardiac electrograms.

Authors:  Elyar Ghafoori; Muammar M Kabir; Jian Cao; Alexei Shvilkin; Larisa G Tereshchenko
Journal:  J Electrocardiol       Date:  2015-05-08       Impact factor: 1.438

5.  A novel lead configuration for optimal spatio-temporal detection of intracardiac repolarization alternans.

Authors:  Eric H Weiss; Faisal M Merchant; Andre d'Avila; Lori Foley; Vivek Y Reddy; Jagmeet P Singh; Theofanie Mela; Jeremy N Ruskin; Antonis A Armoundas
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-23

6.  Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.

Authors:  Larisa G Tereshchenko; Aaron McCabe; Lichy Han; Sanjoli Sur; Timothy Huang; Joseph E Marine; Alan Cheng; David D Spragg; Sunil Sinha; Hugh Calkins; Kenneth Stein; Gordon F Tomaselli; Ronald D Berger
Journal:  Heart Rhythm       Date:  2012-06-29       Impact factor: 6.343

Review 7.  Imaging of Ventricular Fibrillation and Defibrillation: The Virtual Electrode Hypothesis.

Authors:  Bastiaan J Boukens; Sarah R Gutbrod; Igor R Efimov
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

8.  Ascending-ramp biphasic waveform has a lower defibrillation threshold and releases less troponin I than a truncated exponential biphasic waveform.

Authors:  Jian Huang; Gregory P Walcott; Richard B Ruse; Scott J Bohanan; Cheryl R Killingsworth; Raymond E Ideker
Journal:  Circulation       Date:  2012-08-03       Impact factor: 29.690

Review 9.  Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials.

Authors:  Jorge Romero; Rahul Chaudhary; Jalaj Garg; Florentino Lupercio; Neeraj Shah; Rahul Gupta; Talha Nazir; Babak Bozorgnia; Andrea Natale; Luigi Di Biase
Journal:  J Interv Card Electrophysiol       Date:  2017-07-03       Impact factor: 1.900

Review 10.  The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

Authors:  Nicolas Clementy; Alexandre Bodin; Arnaud Bisson; Ana-Paula Teixeira-Gomes; Sebastien Roger; Denis Angoulvant; Valérie Labas; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.